Effective: October 17, 2019
Latest Legislation: House Bill 166 - 133rd General Assembly
(A)(1) As used in this section:
(a) "Prescribed drug" has the same meaning as in section 5164.01 of the Revised Code.
(b) "Psychotropic drug" means, except as provided in division (A)(2) of this section, a drug that has the capability of changing or controlling mental functioning or behavior through direct pharmacological action. "Psychotropic drug" includes all of the following:
(i) Antipsychotic medications, including those administered or dispensed in a long-acting injectable form;
(ii) Antidepressant medications;
(iii) Anti-anxiety medications;
(iv) Mood stabilizing medications.
(2) "Psychotropic drug" excludes a stimulant prescribed for the treatment of attention deficit hyperactivity disorder.
(B) There is hereby created the psychotropic drug reimbursement program. The program shall be administered by the department of mental health and addiction services.
The purpose of the program is to provide state reimbursement to counties for the cost of psychotropic drugs that are dispensed to inmates of county jails in this state. Each county shall ensure that inmates have access to all psychotropic drugs that are prescribed drugs covered by the fee-for-service component of the medicaid program.
The department, based on factors it considers appropriate, shall allocate an amount to each county for reimbursement of such psychotropic drug costs incurred by the county.
(C) The director of mental health and addiction services may adopt rules as necessary to implement this section. The rules, if adopted, shall be adopted in accordance with Chapter 119. of the Revised Code.